PoongLim Pharmatech

What PoongLim Pharmatech does

PoongLim Pharmatech (풍림파마텍) is a South Korea-based medical device manufacturer founded in 1999 and headquartered in the Gunsan Free Trade Zone, Jeollabuk-do. The company designs, manufactures, and supplies syringes, sterile needles, pre-fillable glass barrels, and related medical devices — including its flagship LDV (Low Dead Volume) syringe, which minimizes residual liquid to enable 6+ vaccine doses per vial versus 5 with standard syringes. Its operations are certified under MFDS GMP, ISO 13485, FDA approval, CE marking, ISO 11135, ISO 10993, and DMF Type III standards, allowing export to the US, Japan, India, Saudi Arabia, Mexico, and other markets. The product portfolio spans core PFS/syringe/needle lines plus bone cement, cosmetic, dental, veterinary, blood processing, fat separation, and ophthalmic needle products.

The company's business model combines B2B hardware sales to pharmaceutical manufacturers, hospital procurement channels, and government health agencies with an exclusive domestic distribution franchise for SCHOTT AG's PFS products in Korea (in place since 2002 and restructured post-2025 to a virtually unlimited term). Revenue is generated through direct enterprise sales, export contracts, government procurement, and licensing/distribution margins. FY2024 sales were 93.2 billion KRW with operating profit of 5.4 billion KRW (~5.8% margin); export milestones include a $7M export tower in 2021 and a $50M export contract signed at the World Korean Business Conference. The company employs 251–500 people across its Gunsan headquarters and Saemangeum production complex (Factory 3 operational with 20M units/month LDV capacity; Factory 4 under construction for ophthalmic/joint and diagnostic devices).

In November 2025, bnw Investment and Elio PE acquired approximately 88% of PoongLim Pharmatech for about 1,000 billion KRW, taking the company private; the Cho founding family retained ~12%, with second-generation owner Jo Mi-hee continuing as representative director to manage client relationships and ongoing international expansion including the 2023 Allcare Group joint venture for a Saudi Arabia manufacturing facility.

Name

PoongLim Pharmatech

Legal name

(주)풍림파마텍

Website

https://plpt.co.kr

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

251–500 employees

Short description

PoongLim Pharmatech is a South Korean medical device manufacturer specializing in pre-filled syringes, LDV vaccine syringes, sterile needles, and glass barrel components. The company serves pharmaceutical manufacturers, hospitals, and government health agencies domestically and across the US, Japan, India, and the Middle East.

Ownership category

akta.pro rank

Headquarters

HQ city

Gunsan

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Revenue model

1. Medical Device Manufacturing and Sales: Designs, manufactures, and sells syringes, needles, vials, and related medical devices to pharmaceutical companies, hospitals, and government health agencies. Products include LDV syringes, pre-fillable glass barrels, sterile needles, catheter/cannulas, bone cement syringes, dental syringes, cosmetic syringes, veterinary syringes, blood processing equipment, fat separation equipment, blood collection devices, and polydioxanone sutures. Revenue is generated through direct B2B sales, export contracts, and government procurement.
2. International Distribution Rights (SCHOTT): As the exclusive domestic distributor of SCHOTT's PFS products in Korea, the company earns revenue through importing and distributing SCHOTT glass barrels, vials, and cylinders. The long-term distribution agreement was restructured post-acquisition with virtually unlimited duration.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

No source material was provided in the input to describe the company's core offering.

Product overview

PoongLim Pharmatech (풍림파마텍) is a medical device manufacturer specializing in prefillable syringes, syringes, needles, and medical accessories. The company operates as a single unified product portfolio rather than a platform-plus-modules architecture. Core products include the LDV (Low Dead Volume) Sterile Syringe and Kopac HL Prefillable Glass Barrel as the flagship offerings, complemented by the EZ-Injec sterile needle line (including LDV variants), bone cement syringes, cosmetic syringes, dental syringes, and animal/livestock syringes. The product range also includes blood processing equipment, fat separation equipment, blood collection/transfusion equipment, PDO sutures, prefilled syringe accessories (plunger rods, finger grips), universal catheter cannulas, ophthalmic needles, and sterile needles. The company gained global recognition during the COVID-19 pandemic with its LDV syringe technology that minimizes vaccine waste, enabling more doses per vial.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• LDV syringe yields 6+ vaccine doses per vial vs. 5 doses with standard syringes, increasing vaccination efficiency by 20%+
• +5 more outcomes

Named customers2 records

Segments3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators13 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Becton, Dickinson and Company (BD): Global medical device incumbent with leading positions in syringes, needles, and drug delivery systems serving pharmaceutical manufacturers and hospitals. BD is a broader incumbent whose product portfolio overlaps with PoongLim's LDV syringes, sterile needles, and pre-fillable systems.
• B. Braun: Global medical device and pharmaceutical solutions company with a broad portfolio including syringes, infusion systems, and sterile needles. A broader incumbent whose product overlap with PoongLim's syringes and injection devices creates direct competitive overlap in some segments.

Direct peers

• Stevanato Group: Italian-headquartered provider of drug containment, drug delivery, and diagnostic solutions including glass pre-filled syringes. Directly comparable in PFS systems and contract manufacturing for pharmaceutical customers globally.
• Aptar Pharma: Specialty provider of drug delivery and active material science solutions including pre-filled syringe components. Aptar is explicitly listed as a global partner on PoongLim's website and competes in the same PFS drug delivery category.
• SCHOTT Pharma: Global leader in primary packaging for pharmaceuticals including pre-filled glass syringes. SCHOTT is both PoongLim's core supplier and a direct competitor in PFS systems, making it the closest comparable in product, technology, and customer base.
• West Pharmaceutical Services: Global leader in drug containment and delivery including pre-filled syringe components, elastomeric closures, and injection systems. Directly comparable in PFS and injectable drug delivery technology for pharmaceutical manufacturers.
• Terumo: Japanese medical device manufacturer with a strong PFS and injection systems portfolio serving pharmaceutical companies and hospitals. Directly comparable in pre-filled syringes, needles, and sterile medical devices, and a relevant Asian peer.
• Gerresheimer: European specialty manufacturer of glass and plastic primary packaging for pharma, including pre-fillable syringes. Directly comparable in PFS and injectable device offerings serving global pharmaceutical customers.
• Nipro: Japanese medical device manufacturer producing syringes, needles, and pharmaceutical packaging. Directly comparable in disposable syringes and PFS-related products, with similar geographic focus across Asia and emerging markets.

Emerging players

• Ypsomed: Swiss specialist in injection and infusion systems including pre-filled syringes and pen injectors. Comparable as a focused player in injectable drug delivery, though more oriented toward self-injection devices than commodity PFS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PoongLim Pharmatech